H2APEX Group SCA

XETRA:H2A Germany Specialty Chemicals
Market Cap
$39.56 Million
€38.54 Million EUR
Market Cap Rank
#30071 Global
#3326 in Germany
Share Price
€1.06
Change (1 day)
+1.92%
52-Week Range
€1.04 - €2.44
All Time High
€2.44
About

H2APEX Group SCA develops, manufactures, and operates green hydrogen plants for the de-carbonization of industry and infrastructure in Germany and Luxembourg. It operates through Operations, Project Development, and Storage segments. The Operations segment includes production and selling of green hydrogen, as well as the derivatives electricity and heat generation. The Project Development segment… Read more

H2APEX Group SCA (H2A) - Net Assets

Latest net assets as of June 2025: €15.03 Million EUR

Based on the latest financial reports, H2APEX Group SCA (H2A) has net assets worth €15.03 Million EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€92.03 Million) and total liabilities (€77.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €15.03 Million
% of Total Assets 16.33%
Annual Growth Rate -16.25%
5-Year Change -25.22%
10-Year Change N/A
Growth Volatility 92.68

H2APEX Group SCA - Net Assets Trend (2019–2024)

This chart illustrates how H2APEX Group SCA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for H2APEX Group SCA (2019–2024)

The table below shows the annual net assets of H2APEX Group SCA from 2019 to 2024.

Year Net Assets Change
2024-12-31 €30.33 Million -47.59%
2023-12-31 €57.87 Million -50.02%
2022-12-31 €115.79 Million -2.00%
2021-12-31 €118.16 Million +191.30%
2020-12-31 €40.56 Million -44.92%
2019-12-31 €73.64 Million --

Equity Component Analysis

This analysis shows how different components contribute to H2APEX Group SCA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 216.8% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components €83.87 Million 278.38%
Total Equity €30.13 Million 100.00%

H2APEX Group SCA Competitors by Market Cap

The table below lists competitors of H2APEX Group SCA ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in H2APEX Group SCA's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 57,742,000 to 30,127,000, a change of -27,615,000 (-47.8%).
  • Net loss of 27,900,000 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-27.90 Million -92.61%
Other Changes €285.00K +0.95%
Total Change €- -47.82%

Book Value vs Market Value Analysis

This analysis compares H2APEX Group SCA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.28x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.29x to 1.28x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 €3.67 €1.06 x
2020-12-31 €2.02 €1.06 x
2021-12-31 €5.89 €1.06 x
2022-12-31 €5.77 €1.06 x
2023-12-31 €1.59 €1.06 x
2024-12-31 €0.83 €1.06 x

Capital Efficiency Dashboard

This dashboard shows how efficiently H2APEX Group SCA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -92.61%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -94.37%
  • • Asset Turnover: 0.32x
  • • Equity Multiplier: 3.03x
  • Recent ROE (-92.61%) is below the historical average (-8.99%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 3.42% 5.77% 0.49x 1.22x €-4.84 Million
2020 7.68% 6.85% 0.79x 1.41x €-942.20K
2021 73.68% 6795.71% 0.01x 1.04x €75.24 Million
2022 -3.34% -100.62% 0.03x 1.02x €-15.45 Million
2023 -42.76% -161.40% 0.12x 2.12x €-30.46 Million
2024 -92.61% -94.37% 0.32x 3.03x €-30.91 Million

Industry Comparison

This section compares H2APEX Group SCA's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $18,803,803,535
  • Average return on equity (ROE) among peers: -24.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
H2APEX Group SCA (H2A) €15.03 Million 3.42% 5.12x $6.94 Million
Kureha Corporation (0K1) $162.17 Billion 8.59% 0.53x $845.56 Million
Polwax S.A (1LW) $54.23 Million -71.97% 1.06x $3.33 Million
H&R GmbH & Co. KGaA (2HRA) $287.13 Million 9.37% 1.19x $34.48 Million
Renaissance Oil Corp (2R7) $2.68 Billion 6.64% 1.08x $1.31 Billion
Global New Material International Holdings Limited (69Y) $4.35 Billion 5.56% 0.62x $625.83 Million
Altech Chemicals Ltd (A3Y) $33.88 Million -176.29% 0.32x $18.88 Million
Beijing Media Corporation Limited (BME) $1.20 Billion -7.10% 0.16x $1.77 Million
BRAIN Biotech AG (BNN) $17.59 Million -23.28% 0.43x $40.42 Million
Brenntag SE (BNR) $2.69 Billion 13.57% 1.59x $5.87 Billion
Huabao International Holdings Limited (CEY) $14.56 Billion -7.24% 0.14x $1.44 Billion